Corcept Therapeutics CORT Earnings Call Transcripts

NASDAQ CORT
$75.03 +2.26 (+3.11%)
At close: Nov 9, 2026 · 4:00 PM EST
16 earnings calls on file for Corcept Therapeutics, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Corcept Therapeutics Q3 2026 Earnings Call

Nov 3, 2026 5,059 words · 22 min read
  • Atabak MokariCFO
  • Justin GunnPresident of our Endocrinology division
  • Roberto VieiraPresident of our Oncology division
  • Joseph K. BelanoffChief Executive Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Corcept Therapeutics Earnings Call Transcripts

Calls16
LatestNov 3, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 16 Corcept Therapeutics transcripts Register to get access to Corcept Therapeutics’s earnings call transcripts.